<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Anger and psychopathology in prison inmates
2
Anger and somatization
3
Anger and the behavioral approach system
4
Anger as a cue to truthfulness
5
Anger as a Psychological Risk Factor of Hypertension
6
Anger assessment with the STAXI-CA: psychometric properties of a new instrument for children and adolescents
7
Anger at graphic evidence at Omagh inquest
8
Anger at US transplant waiting times “scare”
9
Anger Attacks in Major Depressive Disorder and Serum Levels of Homocysteine
10
Anger expression and essential hypertension: Behavioral response to confrontation
11
Anger expression in children and adolescents: A review of the empirical literature
12
Anger expression in Swiss adolescents: Establishing measurement invariance across gender in the AX scales
13
Anger expression, coping, and substance use in adolescent offenders
14
Anger expression, partner support, and quality of life in cancer patients
15
Anger in Adolescent Boy Athletes: a Comparison among Judo, Karate, Swimming and Non Athletes
16
Anger in chronic pain: Investigations of anger targets and intensity
17
Anger in healthy men: a PET study using script-driven imagery
18
Anger in prisoners: women are different from men
19
Anger in the Trajectory of Healing From Childhood Maltreatment
20
Anger in UK as discredited doctor is elected to doctorsʹ ruling body
21
Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids
22
Anger Management among Medical Undergraduate Students and Its Impact on Their Mental Health and Curricular Activities
23
Anger Management and Control in Social and Behavioral Sciences: A Systematic Review of Literature on Biopyschosocial Model
24
Anger Management and Factors that Influence Anger in Physicians
25
Anger Management May Save Your Life: New Insights Into Emotional Precipitants of Ventricular Arrhythmias
26
Anger management style and the prediction of treatment outcome among male and female chronic pain patients
27
Anger on ruling not to prosecute Irish doctors
28
Anger over dangerous withdrawal of antipsychotics from Pakistan
29
Anger over handling of Madagascarʹs cholera epidemic
30
Anger response styles and reaction to provocation
31
Anger rumination in Hong Kong and Great Britain: Validation of the scale and a cross-cultural comparison
32
Anger scale and anger types of patients with fifth metacarpal neck fracture
33
Anger scale and anger types of patients with fifth metacarpal neck fracture
34
Anger superiority effect for change detection and change blindness
35
Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer
36
Anger symptoms and “delinquent” behavior in Tourette syndrome with and without attention deficit hyperactivity disorder
37
Anger types and the use of cigarettes and smokeless tobacco among Native American adolescents
38
Anger, aggression, and risky behavior: a comparison of high and low anger drivers
39
Anger, aggression, risky behavior, and crash-related outcomes in three groups of drivers
40
Anger, Anger Expression, and Suicidal Ideation in Korean Adolescents
41
Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk
42
Anger, depression, and coping interactions in headache activity and adjustment: a controlled study
43
Anger, hostility, and male perpetrators of intimate partner violence: A meta-analytic review
44
Anger, negative emotions, and cardiovascular reactivity during interpersonal conflict in women
45
Anger, over-control and serious violent offending
46
Anger, psychopathology and cognitive inhibition: a study of UK servicemen
47
Anger, Suppressed Anger, and Risk of Adverse Events in Patients With Coronary Artery Disease
48
Anger-associated panic attacks in Cambodian refugees with PTSD; a multiple baseline examination of clinical data
49
Anger-in and hostility in myocardial infarction patients
50
Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
51
Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines
52
Anggaran dan Ciri Fizikokimia Sisa Buangan Makanan di Bandar Baru Bangi
53
angian lattice boltzmann method for euler equati
54
Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry
55
Angina and origin of three major coronary arteries from independent ostia in right coronary sinus
56
Angina and sudden cardiac death caused by anomalous right coronary artery origin from above the left coronary cusp
57
Angina bullosa hemorrhagica: an idiopathic intraoral blistering disorder
58
Angina caused by coronary steal phenomenon
59
Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa
60
Angina for 14 years
61
Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program
62
Angina pectoris and myocardial infarction with the use of leuprolife acetate
63
Angina pectoris caused by coronary microvascular spasm
64
Angina pectoris caused by microvascular spasm
65
Angina pectoris caused by microvascular spasm
66
Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli
67
Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling Original Research Article
68
Angina pectoris: a headache
69
Angina reassessed: pain or protector?
70
Angina Self-Management Plan and Quality of Life, Anxiety and Depression in Post Coronary Angioplasty Patients
71
Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects
72
Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: Loss of Preconditioning Mechanism in the Aging Heart?
73
Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
74
Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease
75
Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver
76
Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome
77
Angioarrestin mRNA expression in early-stage lung cancers
78
Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis
79
Angioblasts in peripheral blood
80
Angiocardiographic findings in patients with biphasic T-wave inversion in precordial leads
81
Angiocardiography and magnetic resonance imaging to assess pulmonary regurgitation in repaired tetralogy of Fallot
82
Angiocentric Nasal T-Cell Lymphoma in a Patient with Idiopathic CD4+ Lymphocytopenia
83
Angiodysplasia: New Look at an Old Conundrum
84
Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?
85
Angioedema and urticaria as early presentations of a COVID-19 patient: a case report
86
Angioedema Associated With Droperidol Administration, , ,
87
Angioedema Associated with Haloperidol
88
Angioedema associated with sumatriptan administration
89
Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation
90
Angioedema Due to Lamiaceae Allergy
91
Angioedema Due to Lamiaceae Allergy
92
Angioedema in a Patient with C1 Esterase Inhibitor Deficiency
93
Angioedema related to the ue of hyaluronidae in cataract urgery
94
Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)
95
Angioembolization as an effective alternative for hemostasis in intractable life-threatening maxillofacial trauma hemorrhage: case study
96
Angioembolization in itractable epistaxis — a tertiary care experience
97
Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate
98
Angiofibroma of the Nasal Septum
99
Angiofollicular lymph node hyperplasia (Castlemanʹs disease)
100
Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir
101
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
102
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
103
Angiogenesis and breast cancer
104
Angiogenesis and breast cancer metastasis
105
Angiogenesis and chronic disease
106
Angiogenesis and functional recovery demonstrated after minor stroke
107
Angiogenesis and growth factor expression in a model of transmyocardial revascularization
108
Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model
109
Angiogenesis and hepatocellular carcinoma
110
Angiogenesis and intrauterine growth restriction
111
Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
112
Angiogenesis and Mast Cells Density in Oral and Esophageal Squamous Cell Carcinomas
113
Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia
114
Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer
115
Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro
116
Angiogenesis and musculogenesis as two facets of inflammatory post-ischemic tissue regeneration
117
Angiogenesis and Nitric Oxide in Elderly Men after Continuous and Interval Aerobic Training
118
Angiogenesis and placental growth in normal and compromised pregnancies
119
Angiogenesis and Tumor-Associated Macrophages in Different Grades of Oral Squamous Cell Carcinoma, Verrucous Carcinoma and Epithelial Dysplasia via Immunohistochemical Assessment of Expression of CD34 and CD68 Markers
120
Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum
121
Angiogenesis as targeted breast cancer therapy
122
Angiogenesis assays
123
ANGIOGENESIS EFFECTS OF CHINESE HERBAL SALVIA MILTIORRHIZA AFTER ACUTE MYOCARDIAL INFARCTION IN RATS
124
Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?, ,
125
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
126
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
127
Angiogenesis in bone fracture healing: A bioregulatory model
128
Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence, ,
129
Angiogenesis in chronic myelogenous leukaemia
130
Angiogenesis in chronic myelogenous leukaemia
131
Angiogenesis in colon hyperplastic polyp
132
Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters
133
Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis
134
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation
135
Angiogenesis in ischemic human myocardium: clinical results after 3 years
136
Angiogenesis in Ischemic Stroke Patients Aged 30 - 80 years at Gatot Subroto Army Central Hospital (RSPAD) Jakarta
137
Angiogenesis in neovascularized free muscle grafts
138
Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression
139
ANGIOGENESIS IN OPEN TIBIAL FRACTURES: A COMPARISON OF MUSCLE AND FASCIOCUTANEOUS FLAPS
140
Angiogenesis in ovarian cancer
141
Angiogenesis in ovarian follicular and luteal development
142
Angiogenesis in primary and metastatic epithelial ovarian carcinoma, ,
143
Angiogenesis in Rat Ischemic Hindlimb: Role of Human Bone Marrow-Derived Mesenchymal Stem Cells Transplantation
144
Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases
145
ANGIOGENESIS IN TISSUE ENGINEERING
146
Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures
147
Angiogenesis induced by autologous whole bone marrow stem cells seeded on collagen scaffolds in silicone nerve tubes. An experimental study
148
Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants
149
Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale
150
Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation
151
Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers Original Research Article
152
Angiogenesis inhibitors derived from thalidomide
153
Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization
154
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction
155
Angiogenesis modulatory activity of SC-CO2 leaf extract of guyabano (Annona muricata Linn.) using chick embryo chorioallantoic membrane assay
156
Angiogenesis of the ovary,
157
Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation
158
Angiogenesis with recombinant fibroblast growth factor-2 for claudication
159
Angiogenesis with recombinant fibroblast growth factor-2 for claudication
160
ANGIOGENESIS WITHIN ATHEROSCLEROTIC LESIONS BY STEM/PROGENITOR CELLS
161
Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?
162
Angiogenesis, myogenesis and cell therapy I
163
Angiogenesis, Myogenesis, and Cell Therapies
164
Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease
165
Angiogenesis/myogenesis cell therapy
166
Angiogenesis/myogenesis/cell therapy II
167
Angiogenesis: A Critical Role in Locally Aggressive Behavior of Keratocystic Odontogenic Tumor
168
Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT)
169
Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis
170
Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice
171
Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane
172
Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro
173
Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors
174
Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat
175
ANGIOGENIC EFFECTS OF A NEW HMG-COA REDUCTASE INHIBITOR, PITAVASTATIN
176
Angiogenic Effects of Aerobic Training and Royal Jelly Consumption with Emphasis on the Role of miR-126 and miR-210 in the Aortic Artery of Ovariectomized Diabetic Rats
177
Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
178
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells
179
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease
180
Angiogenic growth factors in human dentine matrix
181
Angiogenic growth factors released in human dental pulp following orthodontic force
182
Angiogenic induction and cell migration in an orthopaedically expanded maxillary suture in the rat
183
Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
184
Angiogenic response induced by acellular femoral matrix in vivo
185
Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness
186
Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction
187
Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study
188
Angiogenin and osteopontin and coronary collateral circulation
189
Angiogenin plasma levels during pregnancy
190
Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid, , , ,
191
Angiograph image restoration with the use of rule base fuzzy 2D Kalman filter
192
Angiographic 5-year follow-up study of right gastroepiploic artery grafts
193
Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)
194
Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents
195
Angiographic Analysis of the Anatomic Relation of Coronary Arteries to Mitral and Tricuspid Annulus and Implications for Radiofrequency Ablation
196
Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)
197
Angiographic anatomical variation of origin of left circumflex coronary artery in Basrah
198
Angiographic anatomy of the grafted left internal mammary artery
199
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction tria
200
Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial
201
Angiographic and clinical outcome following coronary stenting of small vessels : comparison with coronary stenting of large vessels
202
Angiographic and clinical outcome of mild to moderate nonocclusive unstented coronary artery dissection and the influence on coronary flow velocity reserve
203
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction
204
Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts
205
Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis
206
Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations
207
Angiographic and Interventional Radiological Management of Obscure Overt Gastrointestinal Bleeding
208
Angiographic and intravascular ultrasound predictors of in-stent restenosis
209
Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents
210
Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage
211
Angiographic and morphologic features of the left ventricle in Ebsteinʹs malformation
212
Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter
213
Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease
214
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
215
Angiographic and volumetric intravascular ultrasound comparison between direct Sirolimus-Eluting stent implantation versus predilation
216
Angiographic aspects of ruptured plaque in patients with acute myocardial infarction: correlation with clinical and laboratory variables
217
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
218
Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia
219
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes
220
Angiographic changes in vein grafts: Stable surrogate or seductive siren?
221
Angiographic Characteristics of Coronary Disease and Postresuscitation Electrocardiograms in Patients With Aborted Cardiac Arrest Outside a Hospital
222
Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction, ,
223
Angiographic complications in CADASIL
224
Angiographic complications of primary angioplasty
225
Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study
226
Angiographic correlates of “spotty” coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms
227
Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery
228
Angiographic Correlates of Graft Patency and Relationship to Clinical Outcomes
229
Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI)
230
Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty, ,
231
Angiographic embolization for arrest of bleeding after penetrating trauma to the abdomen
232
Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm
233
Angiographic Evaluation of Myocardial Perfusion in Patients With Syndrome X
234
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
235
Angiographic evaluation of traumatic arterial injuries of the upper limbs: a retrospective study
236
Angiographic Evolution of Intracoronary Thrombus and Dissection Following Percutaneous Transluminal Coronary Angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial)
237
Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery
238
Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome
239
Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angin and previous bypass surgery
240
Angiographic features, surgical management and outcomes of proximal middle cerebral artery aneurysms
241
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
242
Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience
243
ANGIOGRAPHIC FINDINGS IN 130 PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
244
Angiographic findings in Buerger disease
245
Angiographic findings in monozygotic twins with coronary artery disease
246
Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention
247
Angiographic findings in tumoral calcinosis
248
Angiographic Findings of Patients with Blunt or Penetrating Extremity Injuries: Focus on Indications and Contraindications
249
Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Transluminal Coronary Angioplasty
250
Angiographic Follow-up of Internal Thoracic Artery for Free Bypass Grafting
251
Angiographic follow-up results of STent versus Atherectomy Randomized Trial (START)
252
Angiographic Lesion Severity and Subsequent Myocardial Infarction
253
Angiographic Localization of Potential Culprit Coronary Arteries in Patients With Interatrial Block Following a Positive Exercise Tolerance Test
254
Angiographic methods to assess human coronary angiogenesis
255
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
256
Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)
257
Angiographic Patency of the Radial Artery Conduit in Coronary Artery Bypass Grafting
258
Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents
259
Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention
260
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation
261
Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction
262
Angiographic plaque complexity: the tip of the unstable plaque iceberg
263
Angiographic Predictors and Clinical Outcome of Acute Side Branch Occlusion after Coronary Artery Stent Implantation
264
Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery: A Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts Original Research Article
265
Angiographic predictors of adverse outcomes in the modern interventional era
266
Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts
267
Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization
268
Angiographic predictors of new coronary occlusions
269
Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])
270
Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial
271
Angiographic presence of myocardial bridge after successful percutaneous transluminal coronary angioplasty
272
Angiographic presentation of coronary artery spasm in heart transplant recipients
273
Angiographic profile in patients with congenital anomalous origin of the coronary arteries
274
Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement
275
Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses
276
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)
277
Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions
278
Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia
279
Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus
280
Angiographic severity and extent of coronary artery disease in type 1 diabetes
281
Angiographic severity of coronary artery disease in patients with metabolic syndrome
282
Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis
283
Angiographic significance of a discordant ST-segment elevation of ≥5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction
284
Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden Original Research Article
285
Angiographic study of aorta, coronary arteries, and left ventricular performance after neonatal arterial switch operation for simple transposition of the great arteries, ,
286
Angiographic study of Moyamoya disease and histological study in the external carotid artery system
287
Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled Trials Original Research Article
288
Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial
289
Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
290
Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation
291
Angiographic, ultrasonic, and angioscopic assessment of the coronary artery wall and lumen area configuration after directional atherectomy: The mechanism revisited
292
Angiographical and computed tomographic findings in diffuse pulmonary arteriovenous fistulas
293
Angiographical study of ramus intermedius coronary artery in Basrah
294
Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing
295
Angiographically evident atherosclerotic stenosis associated with myocardial bridging and risk factors for the artery stenosis located proximally to myocardial bridging
296
Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemi and familial combined hyperlipidemia: Correlation with high density lipoproteins
297
Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events
298
Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours
299
Angiography and interventional cardiology
300
Angiography and interventional cardiology Review Article
301
Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction
302
Angiography of potential cardiac donors
303
Angiography versus intravascular ultrasound assessment of coronary stent placement: observations from the AVID study
304
Angiography; an Inducer of TGF-Β during Early Atherosclerosis
305
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
306
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
307
Angioid streaks and other ocular complications of Pagetʹs disease of bone
308
Angioimmunoblastic lymphadenopathy-like T-cell lymphoma A case report and immunologic study
309
Angiokeratoma corporis diffusum without systemic features in a young Kashmiri female: a rare occurrence
310
Angioleiomyoma in the tonsil: an uncommon tumour in a rare site
311
Angioleiomyoma of the diaphragm
312
Angioleiomyoma of the Hand: A Case Series and Review of the Literature
313
Angioleiomyoma: a benign tumor with karyotypic aberrations
314
Angiolipoma of the breast with microcalcification: Mammographic, sonographic, and histologic appearances
315
Angiolymphoid hyperplasia with eosinophilia
316
Angiolymphoid hyperplasia with eosinophilia
317
ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA – A RARE ENTITY
318
Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy
319
Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis
320
Angiomatoid fibrous histiocytoma in mediastinum
321
Angiomatoid Fibrous Histiocytoma, A Great Mimicker – A Short Series of 3 Cases with EWSR1 Fusion
322
Angiomyofibroblastoma mimicking an inguinal hernia: a challenging diagnosis in a male patient
323
Angiomyofibroblastoma of the Vaginal Portion
324
Angiomyofibroblastoma of the Vulva
325
Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair
326
Angiomyolipoma and Malignant PEComa: Discussion of TwoRare Adrenal Tumors
327
Angiomyolipoma of the Adrenal Gland: A Case Report
328
Angiomyoma of the Hard Palate
329
Angiomyxolipoma; Report of a new case in subcutaneous tissue and review of the literature
330
Angiomyxoma Presenting as an Unusual Vaginal Mass
331
Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis
332
Angioneogenesis in rheumatoid arthritis
333
Angioneogenesis in rheumatoid arthritis
334
ANGIOPEPTIDES: NOVEL PEPTIDES THAT INDUCE ANGIOGENESIS
335
ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES
336
ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES
337
Angioplasty and stenting of the distal coronary anastomosis for graft failure immediately after coronary artery bypass grafting
338
Angioplasty for acute myocardial infarction in community hospital without surgical back-up: Response to Wharton and Angelini publications “should guidelines be changed?: Not whether but when”
339
Angioplasty for coarctation in different aged patients
340
Angioplasty for intermittent claudication
341
Angioplasty for lower-limb ischaemia: time for randomised controlled trials
342
Angioplasty for the late stent thrombosis, the new technical challenge: A single centre experience
343
Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow
344
Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup
345
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA
346
Angioplasty of a left anterior descending artery originating from the right sinus of Valsalva (discussion in decision making)
347
Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function
348
Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angin (TAUSA) Trial
349
Angioplasty of the internal thoracic artery bypass-graft an alternative to reoperation
350
Angioplasty or Surgery for Multivessel Coronary Artery Disease: Comparison of Eligible Registry and Randomized Patients in the EAST Trial and Influence of Treatment Selection on Outcomes
351
Angioplasty through a stent side door
352
Angioplasty versus bypass surgery
353
Angioplasty versus bypass surgery
354
Angioplasty versus bypass surgery
355
Angioplasty versus intravenous thrombolysis for acute myocardial infarction
356
Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial
357
Angioplasty, inflammation, and antiplatelet agents
358
Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein
359
Angiopoietin 2 Level in Type 2 Diabetic Patients with Cardiovascular Complications
360
Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males
361
ANGIOPOIETIN-1 AND -2 MEDIATE PROINFLAMMATORY RESPONSES IN HUMAN ENDOTHELIAL CELLS
362
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
363
Angiopoietin-1 supports induction of hematopoietic activity in human CD34− bone marrow cells
364
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
365
ANGIOPOIETIN-2 IS AN AUTOCRINE REGULATOR OF ENDOTHELIAL CELL RESPONSIVENESS AND VASCULAR HOMEOSTASIS
366
Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors
367
Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome
368
Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway
369
Angiopoietin-like proteins: Another player in the metabolic field
370
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
371
Angiopoietin-like-4 is a potential angiogenic mediator in arthritis
372
Angiopoietins in angiogenesis
373
Angiopoietins in malignancy
374
Angiopoietins: a link between angiogenesis and inflammation
375
Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast
376
Angiosarcoma as a sequela of breast cancer treatment with lumpectomy and radiotherapy
377
Angiosarcoma at Dialysis Fistula Site in a Patient on Continuous Ambulatory Peritoneal Dialysis
378
Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose
379
Angiosarcoma of Kidney A Case Report and Review of Literature
380
Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma
381
Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook
382
Angiosarcoma of the chest wall
383
Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts
384
Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy
385
Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena
386
Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion
387
Angiosarcoma of the right atrium: A diagnostic dilemma
388
Angiosarcoma of the small intestine
389
Angiosarcoma: complication of breast conservation treatment
390
Angiosarcome mammaire primitif : à propos de deux cas
391
Angioscopic and Virtual Histology Intravascular Ultrasound Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis
392
Angioscopic Assessment of Coronary Lesions Underlying Thrombus
393
Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction
394
Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents
395
Angioscopic Coronary Macromorphology After Thrombolysis in Acute Myocardial Infarction
396
Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism
397
Angioscopic evaluation of angiographically complex coronary lesions,
398
Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes
399
Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent
400
Angioscopic Evaluation of Rotational Atherectomy Followed by Additional Balloon Angioplasty Versus Balloon Angioplasty Alone in Coronary Artery Disease: Prospective, Randomized Study
401
Angioscopic findings during coronary angioplasty of coronary occlusions
402
Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation
403
Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions Original Research Article
404
Angioscopic identification of coronary thrombus in patients with postinfarction angina
405
Angioscopic versus angiographic detection of thrombus during coronary interventional procedures
406
Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology
407
Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty
408
Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: A case series
409
Angiosome-targeted isolated tibial angioplasty for healing of ischemic foot ulcer: a retrospective study
410
Angiosperm DNA contamination by endophytic fungi: Detection and methods of avoidance
411
Angiosperms (seagrass) within the EU water framework directive: A UK perspective
412
Angiostrongylus eosinophilic meningitis in Egypt
413
Angiostrongylus vasorum from South America and Europe represent distinct lineages
414
Angiotenin II and vacular endothelial growth factor in the vitreou fluid of patient with diabetic macular edema and other retinal diorder
415
Angiotensin (1–7) and Apelin co-therapy: New strategy for heart failure treatment of rats
416
Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells
417
Angiotensin 1-7 Administration Increases Renal Blood Flow in the Absence of Bradykinin B2 Receptor in Ovariectomized Estradiol Treated Rats: The Role of Mas Receptor
418
Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
419
Angiotensin 2 type 1 receptor blocker attenuates atrial structural remodeling in spontaneously hypertensive rats: Role of the suppression of atrial oxidative stress
420
Angiotensin and asymmetric fetal growth
421
Angiotensin and vascular fibrinolytic balance
422
Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by L-carnitine
423
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade
424
Angiotensin blockade for hypertension: a promise fulfilled
425
Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats
426
Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial Infarction
427
Angiotensin converting enzyme (ACE D/I) polymorphism and its relation to liver fibrosis progression in Egyptian patients with chronic hepatitis C virus infection
428
Angiotensin Converting Enzyme (ACE) Activity Levels in Insulin-independent Diabetes Mellitus and Effect of ACE levels on Diabetic Patients with Nephropathy
429
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
430
Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats
431
Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum
432
Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat Heart
433
Angiotensin converting enzyme gene — a candidate gene for addiction to smoking?
434
Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls
435
Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure
436
Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis
437
Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension
438
Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease
439
Angiotensin Converting Enzyme Gene Polymorphism in Aizheimers Disease
440
Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
441
Angiotensin Converting Enzyme Gene Polymorphism in Iranian Patients with Type 2 Diabetes
442
Angiotensin Converting Enzyme Gene Polymorphism Is Not Related to Essential Hypertension in a Greek Population
443
Angiotensin Converting Enzyme I/D Polymorphism and Chronic Hepatitis C Virus Infection
444
Angiotensin Converting Enzyme I/D Polymorphism in Egyptian Patients with Type 2 Diabetes Mellitus
445
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension
446
Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts
447
Angiotensin Converting Enzyme Inhibition Corrects Na+/H+ Exchanger Overactivity in Essential Hypertension
448
Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)
449
Angiotensin converting enzyme inhibitor as an additive treatment after successful balloon dilation of a critical pulmonary valve stenosis
450
Angiotensin converting enzyme inhibitor captopril does not improve exercise tolerance or reduce exercise induced myocardial ischemi in patients with angin pectoris
451
Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese
452
Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death
453
ANGIOTENSIN CONVERTING ENZYME- INHIBITORS ASSOCIATED COUGH: A PROSPECTIVE EVALUATION IN HYPERTENSIVES
454
Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection
455
Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism: An Observational Study among Diabetic Hypertensive Subjects in Malaysia
456
Angiotensin- Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population
457
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimerʹs disease and longevity
458
Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: Ethnic difference of ACE genotype
459
Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis
460
Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris
461
Angiotensin I Converting Enzyme Gene Polymorphism in Chinese Patients With Hypertension
462
Angiotensin I Converting Enzyme Inhibitory Activities of Hydroalcoholic Extracts of Nardostachys jatamansi, Prangos ferulacea and Marrubium vulgare
463
Angiotensin I Modulates Ca-transport Systems in the Rat Heart Through Angiotensin II
464
Angiotensin I retention behavior on Butyl-Sepharose under linear loading chromatographic conditions
465
Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism in Relation to Physical Performance, Cognition and Survival—A Follow-up Study of Elderly Danish Twins
466
Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene
467
Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases
468
Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion
469
Angiotensin I–converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort
470
Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women
471
Angiotensin I-Converting Enzyme Gene Polymorphism and Acute Response to Captopril in Essential Hypertension
472
Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease Original Research Article
473
Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor
474
Angiotensin I-converting enzyme inhibitory compounds in white and red wines
475
Angiotensin I-converting enzyme inhibitory oligo-tyrosine peptides synthesized by α-chymotrypsin
476
Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats
477
Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product
478
Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition
479
Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease
480
Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain
481
Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress
482
Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney
483
Angiotensin II activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells
484
Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes
485
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells
486
Angiotensin II and atherosclerosis
487
Angiotensin II and cardiomyocyte apoptosis in the SHR
488
Angiotensin II and Intracellular Calcium of Adult Cardiac Fibroblasts
489
Angiotensin II and the pathophysiology of cardiovascular remodeling
490
Angiotensin II and trials of cardiovascular outcomes
491
Angiotensin II antagonists block ethanol effects on the aerial righting reflex
492
Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications
493
Angiotensin II antagonists for hypertension: are there differences in efficacy?
494
Angiotensin II antagonists for hypertension: there are differences in efficacy
495
Angiotensin II antagonists for hypertension: there are differences in efficacy: The reply
496
Angiotensin II AT1 Receptor Blockade Improves Renal Perfusion in Hypercholesterolemia
497
Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys
498
Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension
499
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
500
Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance
501
Angiotensin II directly inhibits protein synthesis in murine myotubes
502
Angiotensin II Elevates Nitric Oxide Synthase 3 Expression and Nitric Oxide Production Via a Mitogen-Activated Protein Kinase Cascade in Ovine Fetoplacental Artery Endothelial Cells
503
Angiotensin II enhances cardiac Na+/Ca2+ exchanger current via an autocrine release of endothelin
504
Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity
505
Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect
506
Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: A mechanism by which angiotensin II antagonizes cGMP signaling
507
Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway
508
Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels
509
Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors
510
Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro
511
Angiotensin II induces DNA injury in human umbilical artery smooth muscle cells via a mechanism which involves hydrogen peroxide
512
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice
513
Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor
514
Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast
515
Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling Pathway
516
Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells
517
Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice
518
Angiotensin II inhibition and prevention of atrial fibrillation and stroke
519
Angiotensin II inhibition during myocardial ischemia–reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction
520
Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons
521
Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells
522
Angiotensin II inhibits the forearm vascular response to increased arterial pressure in humans
523
Angiotensin II Mechanisms in Ischemic Heart Disease: Pathophysiology and Survival
524
Angiotensin II mechanisms in the renal responses to hypertension and diabetes mellitus.
525
Angiotensin II Modulates ANP-R2/ANP-C Receptor-mediated Inhibition of Adenylyl Cyclase in Vascular Smooth Muscle Cells: Role of Protein Kinase C
526
Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent Manner
527
Angiotensin II Plays an Important Role in Maintaining Blood Pressure in Postmenopausal Women Receiving Hormone Replacement Therapy
528
Angiotensin II Potentiates DNA Synthesis in AT-1 Transformed Cardiomyocytes
529
Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo
530
Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin
531
Angiotensin II Receptor Antagonist Blocks the Expression of Connexin43 Induced by Cyclical Mechanical Stretch in Cultured Neonatal Rat Cardiac Myocytes
532
Angiotensin II receptor antagonists Review Article
533
Angiotensin II receptor blockade and end-organ protection
534
Angiotensin II receptor blockade by losartan reduces the incidence of heart failure after an MI in rat
535
Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog
536
Angiotensin II receptor blockade in diabetic nephropathy
537
Angiotensin II receptor blockade in diabetic nephropathy
538
Angiotensin II receptor blockade reduces expression of basic fibroblast growth factor mRNA in the balloon injured rat carotid artery. Quantification by competitive polymerase chain reaction
539
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article
540
ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN ENHANCES GLUCOSE-INDUCED INSULIN SECRETION
541
Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation
542
Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension
543
Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity
544
Angiotensin II receptor blockers: review of the binding characteristics
545
Angiotensin II Receptor Subtypes and Biological Responses in the Rat Heart
546
Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart Failure
547
Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease Original Research Article
548
Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats
549
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell
550
Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR
551
Angiotensin II Release From Rabbit Intrarenal Arteries: A Critical Assessment
552
Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway
553
Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and Myofibroblasts
554
Angiotensin II stimulates cardiac chloride/bicarbonate exchange activity by phosphorylation of serine 67 of AE3
555
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
556
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
557
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Original Research Article
558
Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts: T-type Ca channel blockade in vascular smooth muscle cells causes G1S cell cycle arrest
559
Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties
560
Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non–insulin-dependent diabetes mellitus
561
Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide
562
Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients
563
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure
564
Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer
565
Angiotensin II Type 1 Receptor Blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia
566
Angiotensin II type 1 receptor blockade improves cardiac expression of hsp72 and tolerance against ischemia/reperfusion injury in insulin resistance rat
567
Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model
568
Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
569
Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study
570
Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population
571
Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome
572
Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With Hypertension
573
Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events
574
Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation
575
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists
576
Angiotensin II type-I receptor antagonists in the treatment of heart failure
577
Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells
578
Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension
579
Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart
580
Angiotensin II, VEGF, and diabetic retinopathy
581
Angiotensin II, VEGF, and diabetic retinopathy
582
Angiotensin II, VEGF, and diabetic retinopathy
583
Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid
584
Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis
585
Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons
586
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
587
Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes
588
Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts
589
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma
590
Angiotensin receptor antagonists
591
Angiotensin receptor antagonists: focus on losartan
592
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome
593
Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: A possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform Original Research Article
594
Angiotensin Receptor Blocker and N-Acetyl Cysteine for Reduction of Proteinuria in Patients With Type 2 Diabetes Mellitus
595
Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL
596
Angiotensin Receptor Blockers and Cardiovascular Protection: Are We ONTARGET?
597
Angiotensin receptor blockers and diuretics as combination therapy: clinical implications
598
Angiotensin Receptor Blockers and Magnesium Status in Essential Hypertension
599
Angiotensin receptor blockers in heart failure: A work in progress
600
Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
601
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
602
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
603
Angiotensin Receptor Blockers: Current Status and Future Prospects
604
Angiotensin receptor blockers: how important is selectivity?
605
Angiotensin receptor blockers—finally the evidence is coming in: IDNT and RENAAL
606
Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
607
Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits Original Research Article
608
Angiotensin Receptors in Cardiac and Renal Hypertrophy in Rats
609
Angiotensin receptors: history and mysteries
610
Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis
611
Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia
612
Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons
613
Angiotensin-(1–7) and vasopeptidase inhibition
614
Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala
615
ANGIOTENSIN, BRADYKININ AND CONVERTING ENZYME IN IMPOSED AND PHYSIOLOGICAL FLOW-RELATED ARTERIAL REMODELING.
616
Angiotensin, fibrinolysis, and vascular homeostasis
617
Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic
618
Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease
619
Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis
620
Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells
621
angiotensin-converting enzyme 2 (ace2) gene polymorphism in patients with type 2 diabetes (t2dm) in thi-qar, iraq
622
Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy
623
Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries
624
Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease
625
Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy
626
Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population
627
Angiotensin-converting Enzyme and Renin Inhibition Activities, Antioxidant Properties, Phenolic and Flavonoid Contents of Cuphea ignea A. DC.
628
Angiotensin-Converting Enzyme Assay Optimization:Influence of Various Buffers and Their Concentrations
629
Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure
630
Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension
631
Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape
632
Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: The Rotterdam study
633
Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients
634
Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
635
Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy
636
Angiotensin-Converting Enzyme Gene Polymorphism in Systemic Hypertension
637
Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis
638
Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction
639
Angiotensin-converting enzyme genetic variants do not influence response to risperidone in autistic children
640
Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes
641
Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise Original Research Article
642
Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women
643
Angiotensin-Converting Enzyme I/D Polymorphism in Behçet’s Disease
644
Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study
645
Angiotensin-Converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats
646
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet
647
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients
648
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium
649
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Original Research Article
650
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the othe
651
Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non–ST-elevation acute coronary syndromes
652
Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling
653
Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
654
Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane
655
Angiotensin-converting enzyme inhibition to enhance vascular health—clinical and research models
656
Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise
657
Angiotensin-Converting Enzyme Inhibitor as a Marker, Not a Risk Factor, for Poor Prognosis
658
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Original Research Article
659
Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure,
660
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure
661
Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?
662
Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy
663
Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion
664
Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis
665
Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction
666
Angiotensin-Converting Enzyme Inhibitor Therapy at the Time of Coronary Artery Bypass Surgery: When a Friend Turns Mean-Spirited
667
Angiotensin-converting enzyme inhibitor treatment after myocardial infarction: A selective approach for maximum benefit
668
Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction
669
Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
670
Angiotensin-converting enzyme inhibitors after myocardial infarction: Indications and timing
671
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease
672
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study
673
Angiotensin-converting enzyme inhibitors and myocardial infarction: A class effect?
674
Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study
675
Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy
676
Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman
677
Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy
678
Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation
679
Angiotensin-Converting Enzyme Inhibitors Can Increase the Transvalvular Gradient Among Patients With Aortic Stenosis
680
Angiotensin-converting enzyme inhibitors in adults after the mustard procedure
681
Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease
682
Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Original Research Article
683
Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective, ,
684
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials Original Research Article
685
Angiotensin-Converting Enzyme Inhibitors Potentiate Preconditioning Through Bradykinin B2 Receptor Activation in Human Heart
686
Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level
687
Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients
688
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists and Calcium Channel Blocking Agents: Review of Potential Benefits and Possible Adverse Reactions
689
Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure
690
Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?
691
Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit
692
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk
693
Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in General Population of West Azarbaijan, Iran
694
Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris
695
Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms
696
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults
697
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply
698
Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy
699
Angiotensin-converting enzymeinhibitors and angiotensin iireceptor blockers synergistically increasecoronary blood flow in canine ischemic myocardium: Role of bradykinin
700
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training
701
Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial
702
Angiotensin-converting-enzyme inhibitors in early pregnancy
703
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
704
Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats
705
Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates
706
Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products
707
Angiotensin-I-converting enzyme inhibitory activity and bitterness of enzymatically-produced hydrolysates of shrimp (Pandalopsis dispar) processing byproducts investigated by Taguchi design
708
Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats
709
Angiotensin-II receptor antagonist losartan improves the exercise tolerance in patients with symptomatic congestive heart failure
710
Angiotensin-II type 1 receptor polymorphism is associated with an increased vasoreactivity to angiotensin II in human arteries
711
Angiotensin-II-receptor inhibitors in pregnancy
712
Angiotensin-II-receptor inhibitors in pregnancy
713
Angiotensin-II-receptor inhibitors in pregnancy
714
Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: The atherosclerosis risk in communities and the NHLBI family heart studies Original Research Article
715
Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia
716
Angiotensinogen expression by rat epididymis: evidence for an intrinsic, angiotensin-generating system
717
Angiotensinogen Gene M235T and T174M Polymorphisms in Diabetic Nephropathy in a Bangladeshi Population
718
Angiotensinogen Gene M235T and T174M Polymorphisms in Essential Hypertension: Relation With Target Organ Damage
719
Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes
720
Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
721
Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease, , ,
722
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial
723
Angiotensinogen genotype affects HDL levels in afro-caribbeans
724
Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease, ,
725
Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients
726
Angiotensinogen Promoter Sequence Variants in Essential Hypertension
727
Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis
728
Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua, ,
729
Angiotensins differentially activate phospholipase d in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats
730
Angiotension AT1Receptor Inhibition in Pacing Induced Heart Failure: Effects on Left Ventricular Myocardial Collagen Content and Composition
731
Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms
732
Angiotropic large B-cell lymphoma with clinical features resembling subacute combined degeneration of the cord
733
AngioVac System Used for Vegetation Debulking in a Patient with Tricuspid Valve Endocarditis: A Case Report and Review of the Literature
734
Angle amplification for nanoradian measurements
735
Angle and aspect dependent dew and fog precipitation in the Negev desert
736
Angle and Context Free Grammar Based Precarious Node Detection and Secure Data Transmission in MANETs
737
Angle- and gender-specific quadriceps femoris muscle recruitment and knee extensor torque
738
Angle and thickness dependence of magnetoresistance peaks in thin nickel films
739
ANGLE AND TIME OF ARRIVAL STATISTICS OF A THREE DIMENSIONAL GEOMETRICAL SCATTERING CHANNEL MODEL FOR INDOOR AND OUTDOOR PROPAGATION ENVIRONMENTS
740
ANGLE AND Z BEAMS IN BENDING: TENSOR MATRIX METHOD FOR SPREADSHEETS
741
ANGLE AND Z BEAMS IN BENDING: TENSOR MATRIX METHOD FOR SPREADSHEETS
742
Angle counts for isothetic polygons and polyhedra
743
Angle criteria for frame sequences and frames containing a Riesz basis
744
Angle decomposition of matrices Original Research Article
745
Angle dependence of intravascular ultrasound imaging and its feasibility in tissue characterization of human atherosclerotic tissue
746
Angle Dependence of Magnetic Oscillations in (TMTSF)2FSO3
747
Angle dependent condensing efficiency of Winston cone in terahertz region
748
Angle dependent laser nanopatterning of poly(ethylene terephthalate) surfaces
749
Angle dependent magnetoresistance oscillation study of the fermi surface of β″-(BEDT-TTF)2AuBr2
750
Angle dependent magnetoresistance oscillations of α-(BEDT-TTF)2KHg(SCN)4 under high pressure
751
Angle dependent magnetoresistance oscillations of β-(BEDT-TTP)2I3
752
Angle dependent X-ray photoemission study on UV-ozone treatments of indium tin oxide
753
Angle design of stator-rotor blades for VLH axial flow turbine using surrogate-based optimization
754
Angle distortion and conformality
755
Angle diversity and rate-adaptive transmission for indoor wireless optical communications
756
Angle estimation for two unresolved targets with monopulse radar
757
Angle Formed Between Patent Ductus Arteriosus and Descending Thoracic Aorta in a Beating Heart: A Helpful Study to Design a Better Device for Occluding Patent Ductus Arteriosus
758
Angle Kappa Measurements: Normal Values in Healthy Iranian Population Obtained With the Orbscan II
759
Angle of arrival estimation using spectral interferometry
760
Angle of Attack Investigations on the Performance of a Diverterless Supersonic Inlet
761
Angle of contact between sheet and die during stretch–bend deformation as determined on the bending-under-tension friction test system
762
Angle of incidence effects in a molecular solid
763
Angle of repose of landslide debris deposits induced by 2008 Sichuan Earthquake
764
Angle Optimization Algorithms For Five-Axis Milling Machines
765
Angle paradigm: A new method to measure right parietal dysfunctions in anorexia nervosa
766
Angle Plates
767
Angle resolved imaging of polymer blend systems: From images to a 3D volume of material morphology
768
Angle Resolved Photoemission Spectroscopy of the InP 001/ surface
769
Angle resolved photoemission studies on Sm2−xCexCuO4: remnant Fermi surfaces and coupling to (π,π) scattering Original Research Article
770
Angle resolved photoemission study of image potential states and surface states on Cu(1 1 1)
771
Angle resolved photoemission study of quasi one-dimensional SrCuO2 by soft X-ray excitation
772
Angle resolved photoemission study of the Ce/Pd(1 1 1) interface
773
Angle resolved photoemission study of the spin-Peierls system α′-NaV2O5
774
Angle resolved ultraviolet photoelectron spectroscopy of oriented sexiphenyl layers
775
Angle resolved XPS of monomolecular layer of 5-chlorobenzotriazole on oxidized metallic surface
776
Angle resolved XPS studies on an anodic oxide formed on Ti–Nb–Sn alloy and the photo-induced change in carbon contaminants adsorbed on its surface
777
Angle resolved XPS study of inhomogeneous specimens of polycrystalline silver covered with uniform graphite overlayers
778
Angle resolved X-ray photoelectron spectroscopy study of Au deposited on Pt and Re surfaces
779
Angle resolved X-ray photoelectron spectroscopy study of Pd/NbOx/Nb interfaces
780
Angle strain and conjugation in conformations of heptafulvenes
781
ANGLE v2.1—New version of the computer code for semiconductor detector gamma-efficiency calculations
782
ANGLE v2.1—New version of the computer code for semiconductor detector gamma-efficiency calculations
783
Angle, energy and mass-resolved ion spectroscopy of core-excited polyatomic molecules
784
Angle, energy and mass-resolved ion spectroscopy of core-excited polyatomic molecules
785
Angle-, field-, temperature-, and size-dependent magnetic circular X-ray dichroism in Au/Co nanoclusters/Au(1 1 1)
786
ANGLE: An autonomous, normative and guidable agent with changing knowledge
787
Angle-adjustable sheath for a dual-stage venous cannula
788
Angle-Analyzer: A Triangle-Quad Mesh Codec
789
Angle-averaged effective proton–carbon analyzing powers at intermediate energies
790
Angle-averaged effective proton–carbon analyzing powers at intermediate energies
791
Angle-correlated spectrum measurement for two neutrons emitted from (n, 2n) reaction with the coincidence detection technique using a pencil-beam DT neutron source
792
Angle-correlated spectrum measurement for two neutrons emitted from (n, 2n) reaction with the coincidence detection technique using a pencil-beam DT neutron source
793
Angled abutments result in increased or decreased stress on surrounding bone of single-unit dental implants: A finite element analysis
794
Angle-dependence of the magnetotransport and Anderson localization in a pressure-induced organic superconductor
795
Angle-dependent cyclotron resonance in organic Q2D conductors
796
Angle-dependent infrared absorption spectroscopy at electrode/electrolyte interfaces
797
Angle-dependent light scattering in materials with controlled diffuse solar optical properties
798
Angle-dependent magnetoresistance oscillations and Fermi surface reordering at high magnetic fields in α-(ET)2KHg(SCN)4
799
Angle-dependent magneto-transport measurements on κ- (BEDT-TTF)2Cu(NCS)2 under pressure
800
Angle-dependent Mِssbauer study of the ground and second new metastable state in Na2[Fe(CN)5NO]·2H2O single crystals
801
Angle-dependent polariton collisional broadening in semiconductor microcavities
802
Angle-dependent switching of granular and multilayer perpendicular media
803
Angle-dependent ultraviolet photoelectron spectroscopy of sputter cleaned polycrystalline noble metals
804
Angle-dependent XPS analysis of silicon nitride film deposited on screen-printed crystalline silicon solar cell
805
Angle-dependent XPS study of functional group orientation for aminosilicone polymers adsorbed onto cellulose surfaces
806
Angle-dependent XPS study of the mechanisms of ‘‘high–low temperature’’ activation of GaAs photocathode
807
ANGLE-DIFFERENTIAL CROSS SECTIONS FOR RADIATIVE RECOMBINATION AND THE PHOTOELECTRIC EFFECT IN THE K, L, AND M SHELLS OF ONE-ELECTRON SYSTEMS CALCULATED WITHIN AN EXACT RELATIVISTIC DESCRIPTION
808
Angle-dispersive diffraction with synchrotron radiation at Laboratório Nacional de Luz Síncrotron (Brazil): potential for use in biomedical imaging
809
Angle-monotonicity of theta-graphs for points in convex position
810
Angle-resolved analysis of desorbed species in pulsed laser ablation on cadmium tungstate single crystal surfaces with different orientations studied by time-of-flight mass spectrometry
811
Angle-resolved and resonant photoemission study of the ZrO-like film on ZrC(1 0 0)
812
Angle-resolved characteristics of silicon photovoltaics with passivated conical-frustum nanostructures
813
Angle-resolved elastic peak electron spectroscopy: Role of surface excitations
814
Angle-resolved elastic-peak electron spectroscopy: Solid-state effects
815
Angle-resolved electron and ion spectroscopy apparatus on the soft X-ray photochemistry beamline BL27SU at SPring-8
816
Angle-resolved electron and ion spectroscopy apparatus on the soft X-ray photochemistry beamline BL27SU at SPring-8
817
Angle-resolved electron-electron and electron-ion coincidence spectroscopy: new tools for photoionization studies
818
Angle-resolved electron–electron and electron–ion coincidence spectroscopy: new tools for photoionization studies
819
Angle-resolved electronic decay of the π*, σ* and Rydberg resonances below the O K-edge in O2
820
Angle-resolved inverse photoemission of H-etched 6H-SiC (0001)
821
Angle-resolved inverse photoemission of the (2×1)-reconstructed 3C-SiC(0 0 1) surface
822
Angle-resolved inverse photoemission of the (2×1)-reconstructed 3C-SiC(0 0 1) surface
823
Angle-resolved ion yield spectroscopy for the 1s → 3π excited states in hot N2O molecules
824
Angle-resolved ion–electron coincidence experiments in molecular photoionization
825
Angle-resolved low-energy ion scattering studies of quasicrystalline Al–Pd–Mn
826
Angle-resolved measurements of product desorption and reaction dynamics on individual sites
827
Angle-resolved photoelectron spectroscopy of the satellite bands accompanying the O 1s mainline of CO2
828
Angle-resolved photoemission electron spectroscopy reveals a Fermi surface remnant with a d-wave like dispersion in the Mott insulator, Ca2CuO2Cl2
829
Angle-resolved photoemission from atomic-layer-resolved quantum well states in Ag/Fe(100)
830
Angle-resolved photoemission from stoichiometric GaN(0 0 0 1)-1 × 1
831
Angle-resolved photoemission measurements of omega-(n-pyrrolyl)alkanethiol self-assembled monolayers using in-situ sample preparation apparatus
832
Angle-resolved photoemission measurements of ω-(n-pyrrolyl)alkanethiol self-assembled monolayers using in-situ sample preparation apparatus
833
Angle-resolved photoemission spectroscopy measurements on (1 × 1) and (5 × 1) Pt(1 0 0)
834
Angle-resolved photoemission spectroscopy of band tails and anomalous kinetics of underdoped cuprates Original Research Article
835
Angle-resolved photoemission spectroscopy of SrCuO2: spin-charge separation?
836
Angle-resolved photoemission spectroscopy study of Fe(1 1 0) single crystal: Many-body interactions between quasi-particles at the Fermi level
837
Angle-resolved photoemission studies of the cuprate superconductors
838
Angle-resolved photoemission study for double Ag nano®lm structures
839
Angle-resolved photoemission study of Ag nanofilms grown on fcc transition-metal (111) substrates
840
Angle-resolved photoemission study of Co nanostructures on vicinal Au(1 1 1) surfaces
841
Angle-resolved photoemission study of CoSi2 nanofilms grown on Si(111) substrates
842
Angle-resolved photoemission study of Cu on ZnO(1 0 0); room temperature deposition and annealing effect
843
Angle-resolved photoemission study of Fe on a vicinal Au (7 8 8) surface
844
Angle-resolved photoemission study of quantized electronic structures on Ag nanofilms
845
Angle-resolved photoemission study of quasi one-dimensional conductor Nb3Te4
846
Angle-resolved photoemission study of the hydrogenated 3C-SiC(0 0 1)-2×1-H surface
847
Angle-resolved photoemission study of the surface electronic structure on NdB6 (110) clean surface
848
Angle-resolved photoemission study on the superconducting iron-pnictides of BaFe2(As,P)2 with low energy photons
849
Angle-resolved photofragmentation of the N K-shell excited CF3CN molecule
850
Angle-resolved spectator decay of vibrationally selected C 1s(2σ)−12π1 excited states in carbon monoxide
851
Angle-resolved study of hydrogen abstraction on Si(1 0 0) and Si(1 1 1): Evidence for non-activated pathways
852
Angle-resolved tunneling study on the anisotropic gap of Bi-2212 superconducting whisker
853
Angle-resolved ultraviolet photoelectron microspectroscopy
854
Angle-resolved ultraviolet photoelectron spectroscopy study on the α-Si(1 1 1)3×3-Bi surface
855
Angle-resolved UPS study and simulation with IAC approximation for oriented monolayer of tetratetracontane (n-C44H90) on Cu(100)
856
Angle-resolved XPS depth-profiling strategies
857
Angle-resolved XPS measurements on copper phthalocyanine thin films
858
Angle-resolved XPS studies on transition layers at SiO2/Si interfaces
859
Angle-resolved X-ray photoelectron spectroscopic study of the interface chemistry between ultra-thin aC overcoat and the magnetic layer on magnetic thin film disks
860
Angle-resolved X-ray photoelectron spectroscopic study of the interface chemistry between ultra-thin a-C overcoat and the magnetic layer on magnetic thin film disks
861
Angle-resolved X-ray photoelectron spectroscopy of topmost surface for LaNiO thin film grown on SrTiO substrate by laser 3 3 molecular beam epitaxy
862
Angle-resolved X-ray photoelectron spectroscopy study of the oxides on Nb surfaces for superconducting r.f. cavity applications
863
Angle-resolved-photoemission study of layer-structured nitride β-HfNCl
864
Anglersʹ perceptions of recreational fisheries and fisheries management in Mallorca
865
Angles between infinite dimensional subspaces with applications to the Rayleigh–Ritz and alternating projectors methods
866
Angles in Laguerre tessellation models for solid foams
867
Angle-scanned photoemission spectrum from Cu(1 0 0): theory vs experiment
868
Angle-scanned photoemission spectrum from Cu(1 0 0): theory vs experiment
869
Anglesite (PbSO4) leaching in citrate solutions
870
Anglesite flotation: a study for lead recovery from zinc leach residue
871
Angle-specific impairment of elbow flexors strength after isometric exercise at long muscle length
872
Angle-stable top-emitting white organic light-emitting devices employing a down-conversion layer
873
Angle-upported phakic intraocular lene followed by laer-aited in itu keratomileui for the correction of high myopia
874
Angle-velocity-resolved measurements of I(2P3/2,1/2) from (CH3I)n cluster photodissociation at 266 and 304 nm
875
Anglicism in the Translated Version of Headlines in Malay Printed Catalogues
876
Angling and recreation values of low-flow alleviation in rivers
877
Angling management organizations: integrating the recreational sector into fishery management
878
Anglo-American nursing theory, individualism and mental health care: a social conflict perspective
879
Anglo-American town planning theory since 1945: three significant developments but no paradigm shifts
880
Anglo-Saxon and German approaches to neoliberalism and environmental policy: The case of financing renewable energy
881
Anglo-Saxon and German life-cycle costing
882
Anglo-Saxon animal husbandry techniques revealed though isotope and chemical variations in cattle teeth
883
Anglo-Saxon Axis in 2003:Blairʹʹs Doctrine and Bush Invasion of Iraq
884
Angolan Cymbopogon citratus used for therapeutic benefits: Nutritional composition and influence of solvents in phytochemicals content and antioxidant activity of leaf extracts
885
Angolaʹs suffering behind a pretence of normality
886
Angor in a child: Left main coronary artery atresia
887
ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ
888
Angry and Aggressive Behavior Across Three Generations: A Prospective, Longitudinal Study of Parents and Children
889
Angry and Aggressive Behavior Across Three Generations: A Prospective, Longitudinal Study of Parents and Children
890
Angry Bird s Revenge: Hepatic Abscesses Secondary to Colonic Perforation
891
Angry memories and thoughts of revenge: The relationship between forgiveness and anger rumination
892
Angry men and disgusted women: An evolutionary approach to the influence of emotions on risk taking
893
Angry parents: a group psychotherapy manual for aggression management training
894
Angry? Letʹs talk about it!
895
ANGST OVER UNIVERSITY RANKINGS
896
Angstrom turbidity and ozone column estimations from spectral solar irradiance in a semi-desertic environment in Spain
897
Angstrom-beam electron diffraction of amorphous materials
898
Angstrom-Range Optical Path-Length Measurement with a High-Speed Scanning Heterodyne Optical Interferometer
899
Anguilla anguilla L. Biochemical and Genotoxic Responses to Benzo[a]pyrene
900
Anguilla anguilla L. genotoxic and liver biotransformation responses to abietic acid exposure
901
Anguilla anguilla L. liver EROD induction and genotoxic responses after retene exposure
902
Anguilla anguilla L. liver ethoxyresorufin O-deethylation, glutathione S-tranferase, erythrocytic nuclear abnormalities, and endocrine responses to naphthalene and β-naphthoflavone
903
Anguilla anguilla L. oxidative stress biomarkers responses to copper exposure with or without β-naphthoflavone pre-exposure
904
Anguilla anguilla L. oxidative stress biomarkers: An in situ study of freshwater wetland ecosystem (Pateira de Fermentelos, Portugal)
905
Anguilla anguillaL. Stress Biomarkers Recovery in Clean Water and Secondary-Treated Pulp Mill Effluent
906
Anguish over angiopathy: Hemolytic uremic syndrome
907
Anguishing Reports of Ambient Air Pollution in Tehran Capital of Iran
908
Angular (cis-stilbazole) geometry in octahedral dimethyldihalidoplatinum(IV) complexes: potential as metallomesogens and X-ray structure of [PtMe2I2(NC5H4CHCHC6H4OC7H15)2]
909
Angular analysis of bremsstrahlung in α-decay
910
Angular analysis of the muon pair asymmetry at LEP 1
911
Angular and energy analysis of HeH+ products from the charge exchange excitation reaction
912
Angular and energy dependences of the surface excitation parameter for electrons crossing a solid surface
913
Angular and energy dependences of the surface excitation parameter for semiconducting III–V compounds
914
Angular and fibrous particles in lung are markers of job categories
915
Angular and hyperangular momentum recoupling, harmonic superposition and Racah polynomials: a recursive algorithm
916
Angular and polarization dependence of Compton scattering from 4He in the Δ-resonance region
917
Angular and polarization effects in relativistic potential scattering of electrons in a powerful laser field
918
Angular and power characteristics of noncollinear acousto-optic tunable filters
919
Angular and radial geometries, charge transfer and binding strength in isolated complexes B⋯ICl: some generalisations
920
Angular and time resolution of neutron time of flight spectrometers
921
Angular and unrestricted limits of one-parameter semigroups in the unit disk
922
Angular and velocity distributions of desorbing molecules in steady-state NO+CO reaction on Pd(110)
923
Angular and velocity distributions of small cluster fragments in neutral (NH3)n scattering off LiF(100) Original Research Article
924
Angular anisotropy of products in the photodissociation of propene at 157 nm
925
Angular characterization of low concentrating PV–CPC using low-cost reflectors
926
Angular collection using solenoids
927
Angular collection using solenoids
928
Angular confinement and concentration in photovoltaic converters
929
Angular correlation of photons emitted from an excited quantum well
930
Angular correlation of ultra-high energy cosmic rays with compact radio-loud quasars
931
Angular correlations and statistical entropy of hard spherocylinders: the isotropic–nematic transition
932
Angular correlations in double ionization of Helium by high-energy Compton scattering
933
Angular correlations in double ionization of Helium by high-energy Compton scattering
934
Angular correlations of high momentum photons at 158 A GeV p+A and Pb+Pb collisions Original Research Article
935
Angular Deformities of the Lower Limb in Children
936
Angular dependence from L3-subshell to M-shell vacancy transfer probabilities for heavy elements using EDXRF technique
937
Angular dependence in photoemission: from atoms to surfaces to atoms
938
Angular dependence of dissociation in steering dominated activated reaction
939
Angular dependence of energy and particle fluxes in a magnetized plasma
940
Angular dependence of forward scattering induced by condensate on greenhouse cladding materials
941
Angular dependence of magnetic reversal in two-phased nanolayers
942
Angular dependence of magnetization reversal process in patterned Co thin films
943
Angular dependence of magnetoresistance in SDW state of (TMTSF)2PF6
944
Angular dependence of magnetoresistance of several Bechgaard salts
945
Angular dependence of particle correlations in pp collisions at 400 GeV/c
946
Angular dependence of particle correlations in π+K+p eractions at 250 GeV/c
947
Angular dependence of quartz fiber calorimeter response
948
Angular Dependence of Rayleigh-Wave Velocity in Prestressed Polycrystalline Media with Monoclinic Texture
949
Angular dependence of shot noise in the presence of Rashba spin–orbit coupling in semiconductor spintronics junctions
950
Angular dependence of the floating potential in a magnetized plasma
951
Angular dependence of the high field phase transition in α-(BEDT-TTF)2TlHg(SCN)4
952
Angular dependence of the magnetic-field driven superconductor–insulator transition in thin films of amorphous indium-oxide
953
Angular dependence of the magnetoresistance of TiSi2 single crystals
954
Angular dependence of the sputtering yield of water ice by 100 keV proton bombardment
955
Angular dependence of the two-electron intex distribution
956
Angular dependence of the unusual first-order transition temperature in single-crystal Gd/sub 5/(Si/sub ~0.5/Ge/sub ~0.5/)/sub 4/
957
Angular dependence of the wall correction factor for air kerma measurements using cylindrical cavity chambers
958
Angular dependence of vicinal carbon-proton coupling constants for conformational studies of the hydroxymethyl group in carbohydrates
959
Angular dependence of vortex matter phase transition in MgB2 single crystal Original Research Article
960
ANGULAR DEPENDENCE OF WAVE REFLECTION IN A LOSSY SINGLE-NEGATIVE BILAYER
961
Angular dependences in electroweak semi-inclusive leptoproduction Original Research Article
962
Angular dependences in inclusive two-hadron production at BELLE Original Research Article
963
Angular dependences of the switching field and coercivity for magnetic multilayer films with strain caused by lattice mismatch
964
Angular dependencies of exchange bias and coercivity in the ferromagnetic/antiferromagnetic bilayers not subjected to field-cooling treatments
965
Angular dependent magnetization studies of α-(BEDT-TTF)2KHg(SCN)4
966
Angular dependent magnetotransport and electronic structure in quasi-one-dimensional organic conductor (TMTSF)2ClO4
967
Angular dependent measurements of the ν=52 fractional quantum Hall effect state at ultra-low temperatures
968
Angular Derivatives of Holomorphic Maps in Infinite Dimensions
969
Angular dimensions of planetary nebulae
970
Angular dispersion of polar phonons in a hexagonal GaN–AlN superlattice
971
Angular displacement-enhanced heterodyne polarimeter for the measurement of optically active media
972
Angular distortion and through-thickness residual stress distribution in the friction-stir processed 6061-T6 aluminum alloy
973
Angular distribution and direct CP violation with perturbative strong phases in B → W decays
974
Angular distribution and polarization of photons in the inclusive decay Λb → Xsγ
975
Angular distribution anisotropy of fragments ejected from methyl iodide clusters: Dependence on fs laser intensity
976
ANGULAR DISTRIBUTION COEFFICIENTS FOR γ-RAY POLARIZATIONS PRODUCED IN POLARIZED CAPTURE REACTIONS
977
Angular distribution for the electron recoil in pair production by linearly polarized - rays on electrons
978
Angular distribution for the electron recoil in pair production by linearly polarized - rays on electrons
979
Angular distribution of Bremsstrahlung photons and of positrons for calculations of terrestrial gamma-ray flashes and positron beams
980
Angular distribution of Cherenkov light from electrons both produced and stopping in water
981
Angular distribution of Cherenkov light from electrons both produced and stopping in water
982
Angular distribution of coherent bremsstrahlung
983
Angular distribution of coherent bremsstrahlung
984
Angular distribution of decay leptons from e+e−→W+W− at threshold
985
Angular distribution of desorbing/permeating deuterium from modified Pd(1 1 1) surfaces
986
Angular distribution of Drell–Yan process at hadron colliders to NLO-QCD in models of TeV scale gravity Original Research Article
987
Angular distribution of ejected electrons from Ba 6pns (J=1) autoionizing states
988
Angular distribution of electrons elastically backscattered from amorphous overlayer systems
989
Angular Distribution of Gamma-Ray Bursts and Weak Lensing
990
Angular distribution of highly charged ions transmitted through metallic microcapillaries
991
Angular distribution of intensity of reflected radiation investigations of the influence of CO2 laser treatment on optical properties of hydrogenated amorphous silicon
992
Angular distribution of leptons in general tt̄ production and decay
993
Angular Distribution of Light Scattered by Single Biological Cells and Oriented Particle Agglomerates
994
Angular distribution of neutrons from heavy ion induced reactions in thick targets
995
Angular distribution of neutrons from heavy ion induced reactions in thick targets
996
Angular distribution of nonlinear harmonic generation in helical undulators: A comparison between experiments and theory
997
Angular distribution of nonlinear harmonic generation in helical undulators: A comparison between experiments and theory
998
Angular distribution of oxide films deposited by multi- or single-component laser ablation
999
Angular distribution of particles sputtered from GaAs by Ar+ and Xe+ ion bombardment
1000
Angular distribution of photoelectrons emitted from solids
